Radiation treatment planning in brain tumours potential impact of 3-0-methyl-6-[ 18F]fluoro-L-DOPA and PET

NuklearMedizin

Volumn 47, Issue 5, 2008, Pages 200-204

  Alheit, H ^a   Oehme, L ^a   Winkler, C ^a   Fuchtner F ^b,c   Hoepping, A ^d   Grabowski, J ^a   Kotzerke, J ^a,c   Beuthien Baumann, B ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Institut für Radiopharmazie   (Germany)

^c INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^d ABX Advanced Biochemical Compounds   (Germany)

Author keywords

3 o methyl6 18f fluoro l dopa; Brain tumour; Multimodal imaging; Positron emission tomography, radiation treatment planning

Indexed keywords

3 O METHYL 6 FLUORODOPA F 18; 6 FLUORODOPA F 18; UNCLASSIFIED DRUG; 3 O METHYL 6 FLUORO DOPA; 3-O-METHYL-6-FLUORO-DOPA; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE;

ADULT; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; TREATMENT PLANNING; BIOPSY; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; GLIOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

BIOPSY; BRAIN NEOPLASMS; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149352855     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0171     Document Type: Article

References (29)

1. Albert FK, Forsting M, Sartor K et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994; 34:45-61.
2. Baumert BG, Lutterbach J, Bernays R et al. Fractionated stereotactic radiotherapy boost after postoperative radiotherapy in patients with high-grade gliomas. Radiother Oncol 2003; 67:183-190.
3. 11C)methionine. Eur J Nucl Med Mol Imaging 2003; 30:1561-1567.
4. 18F-fluoro-L-dopa, a new tumor imaging agent: investigation of transport mechanism in vitro. J Nucl Med 2004; 45: 2116-2122.
5. 18F)fluoro-l-DOPA and its evaluation in brain tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30:1004-1008.
6. Brada M, Baumert B. Focal fractionated conformai stereotactic boost following conventional radiotherapy of high-grade gliomas: a randomized phase III study. A joint study of the EORTC (22972) and the MRC (BRIO). Front Radiat Ther Oncol 1999; 33: 241-243.
7. Burger PC. Pathologic anatomy and CT correlations in the glioblastoma multiforme. Appl Neurophysiol 1983; 46:180-187.
8. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007; 48:1468-1481.
9. 18F-FDG PET. Eur J Nucl Med MoI Imaging 2002; 29: 176-182.
10. Dhermain F, Ducreux D, Bidault F, et al. Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma. Bull Cancer 2005; 92:333-342.
11. 18F)fluoro-L-DOPA. Appl Radiat Isot 2003; 58: 575-578.
12. 18F)fluoro-L-DOPA - a promising substance for tumour imaging. J Lab Compd Radiopharm 1999; 42 (Suppl 1): S267-S269.
13. 11C- methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. Int J Radiat Oncol Biol Phys 2003; 56:1450-1463.
14. Grosu AL, Weber WA, Franz M et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 511-519.
15. 11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 64-74.
16. Halperin EC, Bentel G, Heinz ER et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989; 17: 1347-1350.
17. ICRU-Report. ICRU Report 50. Prescribing, Recording and Reporting Photon Beam Therapy; 1993.
18. ICRU-Report. ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50); 1999.
19. Kortmann RD, Jeremie B, Weller M et al. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Strahlenther Onkol 2003; 179:219-232.
20. 11C)L-methionine positron emission tomography: local comparison with stereotactic histopathology Clin Cancer Res 2004;10:7163-7170.
21. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64:259-273.
22. Manon R, Hui S, Chinnaiyan P et al. The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multi forme. Technol Cancer Res Treat 2004; 3: 303-307.
23. Mosskin M, Ericson K, Hindmarsh T et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30:225-232.
24. 18F]fluoroethyl)- L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005; 128: 678-687.
25. Poetzsch C, Hofheinz F, van den Hoff J. Fast user guided segmentation and quantification of volumes in 3-d datasets. Molec Imag Biol 2005; 7: 152.
26. rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001; 28: 1707-1723.
27. Seither RB, Jose B, Paris KJ et al. Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995; 18: 297-299.
28. Tsao MN, Mehta MP, WhelanTJ et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 2005; 63:47-55.
29. 11C)methionine uptake in brain tumours : initial results of a comparative study. Eur J Nucl Med 2000; 27: 542-549.